CHE vs IR · P/E 24, rev $2.43B vs P/E 49, rev $7.24B
Chemed Corp (CHE) versus Ingersoll Rand Inc (IR) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Not investment advice. Open the CHE and IR stock pages for the full models.
Not investment advice.